cod-blam iv , using four sequential cycles of infusional chemotherapy , high-dose alternating myelosuppressives ( doxorubicin , cyclophosphamide ) , and cycle-active agents ( methotrexate , cytarabine , and etoposide ) produced 88 % crs , 67 % potential cures , and a 64 % dfs at a median follow-up of 24 months .
C0279924
cod-blam iv
C0010583
cyclophosphamide